Mirtazapine Tablet, Film Coated
Product Images NDC 70518-2453

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-2453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine 15mg 70518 2453 01

Mirtazapine is a prescription-only medication. It has an NDC number of 70518-2453-01 and is manufactured by Aurobindo in Nagar, India. The medication should be kept out of the reach of children and stored at 20-26°C (63-77°F), with temperature excursions permitted to 15-30°C (59-86°F) per USP guidelines. The directions for use should be obtained from the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA 15701.*

FDA Label Image

Remedy Label

Mirtazapine is a prescription drug. It is packaged in a bottle with NDC number 70518-2453-00 and an expiration date. The manufacturer is Aurcbindo, Nagar, India 505302. Keep the medication out of reach of children. There are no specific directions provided except to refer to the package insert. The medication must be stored in a dry and cool place, with temperatures ranging from 20-26°C (63-77°F) and excursions permitted up to 15-30°C (59-86°F). The medicine was repackaged by RemedyRepack Inc., Indiana, PA 15701.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.